Prognostic Factors in Hodgkin's Disease

Reference

• Bonadonna, G., Zucali, R., Monfardini, S., et al. (1975) "Combina-tion chemotherapy of Hodgkin's disease with adriamycin, bleomy-cM, vinblastine, and imidazole carboxamide versus MOPP", Cancer, 36, 252–259.
   Google Scholar
• Provencio, M., Garcia-Lopez, F.J., Bonilla, F. and Esparia, P. (1999) "Comparison of the long-term mortality in Hodgkin's disease patients with that of the general population", Ann. Oncol., 10, 1199 — 1205.
   Google Scholar
• Hasenclever, D. and Dielh, V. (1998) "International Prognostic Factors Project on Advanced Hodgkin's disease. A prognostic score to predict tumor control in advanced Hodgkin's disease", N. Engl. J. Med., 339, 1506–1515.
   Google Scholar
• Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. and Tubiana, M. (1971) "Report of the Committee on Hodgkin's disease Staging Classification", Cancer Res., 31, 1860–1861.
   Google Scholar
• Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., et al. (1989) "Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting", J. Clin. Oncol., 7, 1630–1636.
   Google Scholar
• De Vita, V.T. and Serpick, A. (1967) "Combination chemotherapy in the treatment of advanced Hodgkin's disease (abstract)", Proc. Amer. Ass. Cancer Res., 8, 13.
   Google Scholar
• Bonadonna, G., Zucali, R., Monfardini, S., et al. (1975) "Combina-tion chemotherapy of Hodgkin's disease with adriamycin, bleomy-cin, vinblastine, and imidazole carboxamide versus MOPP", Cancer, 36, 252–259.
   Google Scholar
• Kaplan, H.S. and Rosenberg, S.A. (1966) "Extended field radical radiotherapy in advanced Hodgkin's disease", Cancer Res., 26, 1268–1276.
   PubMed Web of Science ®Google Scholar
• Otero Luna, J. and Solsona, F. (1969) "La radioterapia sistemica de la Enfermedad de Hodgkin", Radiologia, 66, 29–44.
   Google Scholar
• Aragon, G. and Otero Luna, J. (1971) "La Enfermedad de Hodgkin en la infancia. Tolerancia immediate a la irradiación sistemica", Rev. Clin. Esp., 121, 561–571.
   PubMedGoogle Scholar
• Urba, W.J. and Longo, D. (1992) "Hodgkin's disease", N. Engl. J. Med., 10, 678–687.
   Google Scholar
• Dixon, DO., McLaughlin, P., Hagemeister, F.B., Freireich, E.J., Fuller, L.M., Cabanillas, F.F., etal. (1987) "Reporting outcomes in Hodgkin's disease and lymphoma", J. Clin. Oncol., 10, 1670–1672.
   Google Scholar
• Carrasco, J.L. (1989) El método estadistico en la investigación médica. Ed. Ciencia 3. Madrid, 4a edición.
   Google Scholar
• Armitage, P. and Berry, G. (1987) Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publication.
   Google Scholar
• Kaplan, E.S. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", J. Am. Stat. Assoc., 53, 457–481.
   Web of Science ®Google Scholar
• Cox, D.R. (1972) "Regression models and life-tables", J. R. Stat. Soc. B., 34, 187–220.
   Google Scholar
• Mantel, N. (1966) "Evaluation of survival data and two new rank order statistics arising in its consideration", Cancer Chemother. Rep., 50, 163–170.
   Google Scholar
• Simon, R. (1986) "Confidence intervals for reporting results of clinical trial", Ann. Intern. Med., 105, 429–435.
   Web of Science ®Google Scholar
• Bodis, S., Henry-Amar, M., Bosq, J., Burgers, J.M., Mellink, W.A., Dietrich, P.Y., et al. (1992) "Late relapse in early-stage Hodgkin's disease patients enrolled in EORTC protocols", J. Clin. Oncol., 11, 225— 232.
   Google Scholar
• Lohri, A., Barnett, M., Fairey, R.N., O'Reilly, S.E., Phillips, G.L., Reece, D., et al. (1991) "Outcome on first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1980", Blood, 77, 2292— 2298.
   Google Scholar
• Viviani, S., Santoro, A., Negretti, A., Bonafante, V., Valagussa, P. and Bonadonna, G. (1990) "Salvage chemotherapy in Hodgkin's disease", Ann. °ilea, 1, 123 — 127.
   Google Scholar
• Fiher, RI., De Vita, V.T., Hubbard, R.N., et al. (1979) "Prolonged disease free survival in Hodgkin's disease with MOPP reinduction after first relapse", Ann. Intern. Med., 90, 761–763.
   Web of Science ®Google Scholar
• Bernhars, J., Fischer, R., Htibner, K., et al. (1992) "Histopatholo-gical classification of Hodgkin's lymphomas", Ann. Oncol., 3, 31 — 33.
   Google Scholar
• Glaser, S.L. (1990) "Hodgkin's disease in black populations: a review of the epidemiologic literature", Semin. Oncol., 17, 643–659.
   Google Scholar
• Gutensohn, N.M. (1982) "Social class and age at diagnosis of Hodgkin's disease. New epidemiologic evidence for the 'two-disease hypothesis", Cancer Treat. Rep., 66, 689–695.
   Google Scholar
• Medeiros, L.J. and Greiner, T.C. (1995) "Hodgkin's disease", Cancer, 75, 357 — 369.
   PubMed Web of Science ®Google Scholar
• Correa, P. and O'Conor, G.T. (1971) "Epidemiologic patterns of Hodgkin's disease", Int. J. Cancer, 8, 192–201.
   PubMed Web of Science ®Google Scholar
• Specht, L. (1991) "Prognostic factors in Hodgkin's disease", Cancer Treat. Rev., 8, 21— 53.
   Google Scholar
• Ranson, M.R., Radford, J.A., Swindell, R., et al. (1991) "An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP", Ann. Oncol., 2, 423–429.
   Google Scholar
• Proctor, S.J., Taylor, P., Donnan, P., et al. (1991) "A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. Scotland and New-castle Lymphoma Group (SNLG) Therapy Working Party", Eur. J. Cancer, 27, 624–629.
   Web of Science ®Google Scholar
• Kant, J.A., Hubbard, S.M., Longo, DL., et al. (1986) "The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease", J. Clin. OncoL, 4, 284— 294.
   Web of Science ®Google Scholar
• Vaughan, B., MacLennan, K.A., Easterling, Mi., etal. (1983) "The prognostic significance of age in Hodgkin's disease: Examination of 1500 patients (BNLI Report N° 23)", Clin. Radio!., 34, 503— 506.
   Google Scholar
• Tubiana, M., Henry-Amar, M., Van Der Werf-Messing, B., et al. (1985) "A multivariate analysis of prognostic factors in early Hodgkin's disease", Int. J. Radiat. OncoL BioL Phys., 11, 23–30.
   PubMed Web of Science ®Google Scholar
• Yancik, R., Ries, L.G. and Yates, J.W. (1986) "Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results program data", Am. J. Obstet. Gynecol., 154, 639–647.
   Web of Science ®Google Scholar
• Dixon, DO., Neilan, B., Jones, S., et al. (1986) "Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group Experience", J. Clin. Oncol., 4, 295 — 305.
   Web of Science ®Google Scholar
• Nixon, A.J., Neuberg, D., Hayes, D.F., et al. (1994) "Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I and II breast cancer", J. Clin. Oncol., 12, 888 — 894.
   Web of Science ®Google Scholar
• Specht, L. and Nissen, N.I. (1989) "Hodgkin's disease and age", Eur. J. Haematol., 43, 127 — 135.
   PubMed Web of Science ®Google Scholar
• Walker, A., Schoenfeld, ER., Lowman, J.T., et al. (1990) "Survival of the older patient compared with the younger patient with Hodgkin's disease. Influence of histologic type, staging, and treatment", Cancer, 65, 1635 — 1640.
   Google Scholar
• Gobbi, PG., Cavalli, C., Federico, M., et al. (1998) "Hodgkin's disease prognosis: a directly predictive equation", Lancet, 1, 675 — 679.
   Google Scholar
• Peterson, BA., Pajak, T.F., Cooper, MR., et al. (1982) "Effect of age on therapeutic response and survival in advanced Hodgkin's disease", Cancer Treat. Rep., 66, 889–898.
   Google Scholar
• Lokich, ii., Pinkus, G.S. and Moloney, W.C. (1974) "Hodgkin's disease in the elderly", Oncology, 29, 484— 500.
   PubMed Web of Science ®Google Scholar
• Longo, DL., Young, R.C., Wesley, M., et al. (1986) "Twenty years of MOPP therapy for Hodgkin's disease", J. Clin. OncoL, 4, 1295 — 1306.
   Google Scholar
• Gobbi, PG., Comelli, M., Grignani, G.E., etal. (1994) "Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD)", Haematologica, 79, 241 — 255.
   Google Scholar
• Tubiana, M., Henry-Amar, M., Werf-Messing, B., et al. (1985) "A multivariate analysis of prognostic factors in early stage Hodgkin's disease", Int. J. Radiat. Oncol. Biol. Phys., 11, 23–30.
   PubMed Web of Science ®Google Scholar
• Munker, R., Hasenclever, D., Brosteann, 0., et al. (1995) "Bone marrow involvement in Hodgkin's disease: An analysis of 135 consecutive cases", J. Clin. Oncol., 13, 403–409.
   PubMed Web of Science ®Google Scholar
• Carde, P., MacKintosh, F.R. and Rosenberg, S.A. (1983) "A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy", J. Clin. OncoL, 1, 146–150.
   Web of Science ®Google Scholar
• Bonadona, G., Valagussa, P. and Santoro, A. (1986) "Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease", Ann. Intern. Med., 104, 739–746.
   Web of Science ®Google Scholar
• Straus, Di., Gaynor, Li., Myers, J., et al. (1990) "Prognostic factors among 185 adults with newly diagnosed advanced Hodg-kin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy", J. Clin. OncoL, 8, 1173 — 1186.
   Web of Science ®Google Scholar
• Selby, P., Patel, P., Milan, S., et al. (1990) "Ch1VPP combination chemotherapy for Hodgkin's disease: long term results", Br. J. Cancer, 62, 279–285.
   Web of Science ®Google Scholar
• Pillai, G.N., Hagemeister, F.B., Velasquez, W.S., et al. (1985) "Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin", Cancer, 55, 691–697.
   Google Scholar
• Fermé, C., Bastion, Y., Brice, P., etal. (1997) "Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Groupe d'Etudes des Lymphomes de l'Adulte Study", Cancer, 80, 1124–1133.
   PubMed Web of Science ®Google Scholar
• Jaffe, H.S., Cadman, E.C., Farber, L.R. and Bertino, J.R. (1986) "Pretreatment hematocrit as an independent prognostic variable in Hodgkin's disease", Blood, 68, 562— 565.
   Google Scholar
• Luoni, M., Fava, S. and Declich, P. (1996) "Bone marrow biopsy for staging Hodgkin's lymphoma: the value of bilateral or unilateral trephine biopsy", J. Clin. Oncol., 14, 682–683.
   Google Scholar
• Myers, CE., Chabner, BA., De Vita, VT., et al. (1974) "Bone marrow involvement in Hodgkin's disease: Pathology and response to MOPP chemotherapy", Blood, 44, 197–204.
   PubMed Web of Science ®Google Scholar
• O'Carroll, D., McKenna, R.W. and Brunning, RD. (1976) "Bone marrow manifestations of Hodgkin's disease", Cancer 38, 1717 — 1728.
   PubMed Web of Science ®Google Scholar
• Ellis, ME., Diehl, L.F., Granger, E., et al. (1989) "Trephine needle bone marrow biopsy in the initial staging of Hodgkin's disease: Sensitivity and specificity of the Ann Arbor staging procedure criteria", Am. J. HematoL, 30, 115 — 120.
   PubMed Web of Science ®Google Scholar
• Spech, T.L. and Nissen, N.I. (1988) "Prognostic factors in Hodgkin's disease stage IV", Eur. J. HaematoL, 41, 359— 367.
   PubMed Web of Science ®Google Scholar
• Rosenberg, S.A. (1971) "Hodgkin's disease of the bone marrow", Cancer Res., 31, 1733 — 1736.
   Google Scholar